Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger CCHC domain-containing protein 9 pseudogene (None established; this is a pseudogene, so standard abbreviations like ZCCHC9 are reserved for the functional (protein-coding) gene, not the pseudogene.)
- Target
- None established; this is a pseudogene, so standard abbreviations like ZCCHC9 are reserved for the functional (protein-coding) gene, not the pseudogene.
- Molecular classification
- Other (Pseudogene; does not fall into main functional classes such as receptor, enzyme, transporter, etc.)
01
Overview
Zinc finger CCHC domain-containing protein 9 pseudogene (LOC100421087, ENSG00000259507) is a non-protein-coding genomic sequence in humans and is classified as a pseudogene. Unlike its protein-coding counterpart (ZCCHC9), which is a member of the CCHC-type zinc finger protein family involved in transcriptional regulation and RNA processing, this pseudogene lacks evidence of protein-coding capability and has no known biological function, disease association, or clinical drug targeting relevance. Pseudogenes may occasionally serve as regulatory elements by acting as sources of non-coding RNAs, but there is no evidence that this specific sequence has any established regulatory role. The information is based on gene family reviews and functional characterization tables, which do not list LOC100421087/ENSG00000259507 as a functional gene or therapeutic target.
- Other names
- LOC100421087ENSG00000259507Zinc finger CCHC domain-containing protein 9 pseudogene
02
Mechanism of action
Not applicable.
03
Biological functions
None established. As a pseudogene, it does not produce a functional protein. The corresponding protein family is involved in transcription regulation and RNA processing, but the pseudogene itself has no demonstrated biological activity.
04
Disease associations
None established for the pseudogene. The functional protein family is connected to cancer and transcriptional regulation, but there is no evidence that the pseudogene itself is involved in disease.
05
Safety considerations
None noted. Since it is a pseudogene and not a functional target, there are no risks associated with therapeutic targeting.
06
Interacting drugs
None known.
07
Biomarkers
None known.
Beyond the preview
Go deeper on Zinc finger CCHC domain-containing protein 9 pseudogene (None established; this is a pseudogene, so standard abbreviations like ZCCHC9 are reserved for the functional (protein-coding) gene, not the pseudogene.).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Zinc finger CCHC domain-containing protein 9 pseudogene (None established; this is a pseudogene, so standard abbreviations like ZCCHC9 are reserved for the functional (protein-coding) gene, not the pseudogene.).